Pub. Date : 2016
PMID : 27207748
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | When the mTOR inhibitor everolimus was added to continued vandetanib treatment, the patient achieved a second 25% reduction of tumor volume (RECIST 1.1) for 8 months. | vandetanib | mechanistic target of rapamycin kinase | Homo sapiens |